🕵️ Citius Oncology, Inc. ($CTOR)
SEC insider & ownership activity, last 12 months · CIK 1851484 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Citius Pharmaceuticals, Inc. trimmed 77.9% → 71.0%. One red-flag 8-K in the window: Delisting notice (3.01), Apr 22, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. | 71.0% | 13D | May 15, 2026 | filing ↗ | |
| Armistice Capital, LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Steven Boyd | 10.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Material agreement (1.01) | May 4, 2026 | filing ↗ |
| New financial obligation (2.03) | May 4, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 4, 2026 | filing ↗ |
| Other events (8.01) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Other events (8.01) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Delisting notice (3.01) | Apr 22, 2026 | filing ↗ |
| Other events (8.01) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Other events (8.01) | Mar 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing ↗ |
| Earnings (2.02) | Feb 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 13, 2026 | filing ↗ |
| Earnings (2.02) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 8, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 8, 2025 | filing ↗ |
| Other events (8.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing ↗ |
| Other events (8.01) | Dec 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 1, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 27, 2025 | filing ↗ |